Molecular Partners AG (MOLN)
NASDAQ: MOLN · IEX Real-Time Price · USD
3.700
+0.060 (1.65%)
Apr 29, 2024, 3:56 PM EDT - Market closed

Molecular Partners AG Revenue

In the year 2023, Molecular Partners AG had annual revenue of $8.38M, a decrease of -95.89%. Revenue in the quarter ending December 31, 2023 was $1.23M, a -57.62% decrease year-over-year.

Revenue (ttm)
$8.38M
Revenue Growth
-95.89%
P/S Ratio
14.51
Revenue / Employee
$50,171
Employees
167
Market Cap
121.56M USD

Revenue Chart

* The company reports in CHF currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20238.38M-195.49M-95.89%
Dec 31, 2022203.87M193.15M1,802.02%
Dec 31, 202110.72M100.50K0.95%
Dec 31, 202010.62M-10.40M-49.47%
Dec 31, 201921.01M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
So-Young International 211.29M
Seres Therapeutics 126.33M
Zomedica 25.19M
Seer, Inc. 16.66M
Vaxart 7.38M
Omega Therapeutics 3.09M
Delcath Systems 2.07M
Sagimet Biosciences 2.00M
Revenue Rankings